Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

166

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

December 20, 2027

Study Completion Date

December 20, 2027

Conditions

Nasopharyngeal CarcinomaMaintenance Therapy

Interventions

DRUG

Capecitabine/Placebo combined with toripalimab

Combined

Trial Locations (1)

SunYat-senU, Guangzhou

All Listed Sponsors

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

collaborator

Zhujiang Hospital

OTHER

lead

XIANG YANQUN

OTHER